Philip Morris
Lead
Fields
- Type
- REPT, REPORT, OTHER
- BIBL, BIBLIOGRAPHY
- Area
- LOGUE,MAYADA/OFFICE
- Request
- Stmn/R1-072
- Named Organization
- Acgih, American Conference of Governmental Industrial Hygienists
- Cas
- Centers for Disease Control
- Epa, Environmental Protection Agency
- Society of Env Geochemistry + Health Tas
- Cas
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- EXTR, EXTRA
- Site
- N426
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- fmp02a00
Document Images
August 21, 1990
Lead
CAS #7439-92-1 (1)
Molecular Weight: 207.2 (1)
Criteria and Standards
EPA. Group B2 Carcinogen
Cancer Potency Factor (CPF): None established due to uncertainty and importance of
other health effects at low levels (2)
Reference Dose (RfD): No threshold level established, since very low levels are known to
cause adverse health effects, especially in children. Current risk assessment
methodology involves calculating the pr;Pcted population distribution of blood lead
levels associated with various exposure scenarios. (2) (15)
Maximum Contaminant Level Goai: 20 Ecg/I, proposed (drinking water) (2)
Ma)dmum Contaminant Level: 50 ,gg/1, pro:.aulgated (drinking water) (2)
Ambient Water Quality Criteria: 50 ltg/1, based on ingesting aquatic organisms and drinking
water (2)
Ambient Water Quality Criteria: 50 gg/l, adjusted for drinking water only (2)
Acute Intake Chronic: 1.4 x 10'3 mg/kg-day, oral (3)
4.3 x 10'4mg/kg-day, inhalation (3)
Health Advisory: 20 µg/day (lifetime, drinldng water) (3)
American Conference of Government Industrial Hygienists:
Threshold Limit Value-Time Weighed Average: 0.15 mg/m3, airborne inorganic dust
and fumes, as Pb (4)
r821h!0.006

Centers for Disease Control:
Elevated Blood Lead Level for Children: 25 pg/dl (associated with a blood
erythrocyte protoporphyrin level of 35 µg/dl or greater (11)
Chenlista and Uses
Lead is a heavy metal that exists in one of three oxidation states 0, +2, and +4. Metallic
lead and common lead minerals are relatively insoluble in water, however, organic lead
compounds are water soluble (5). Metallic lead is used as a major component of many
alloys such as solder, print-type metal, and many bronzes. Lead compounds also have a
wide variety of uses as paint pigments, in storage batteriesm, and in ceramics (1).
Phannacaldnetics
Appro;cimate3y 8% of the lead ingested by human adults is thought to be absorbed.
Absorption rates in children are higher, for example, children are thought to absorb as much
as 45-50% of lead in foods (8). This absorption level is generally higher in animals or
humans that have been fasting. The absorption rate for human infants is approximately
50%. Lead is also absorbed after inhalation; reported pulmonary deposition rates as range
from :30% to 50%.
After being absorbed by the body, most lead compounds dissociate, yielding inorganic lead.
Tetrac;tbyl and tetramethyl leads are dealkylated to tri- and di- alkyl compounds which are
more tcWc than the parent compounds. In human adults, under conditions of long-term
exposiu°e, approximately 95% of the total amount of lead found in the body is localized in
the skeleton. In the blood, most- lead is found in the erythrocytes. Lead also readily crosses
the placenta. In most species, the main route of excretion is through the bile. However, in
babo=s and humans, urine appears to be the primary route (5,8).
T2 2 r821h!0.006

At high exposure levels, lead produces encephalopathy, gastrointestinal effects, anemia,
nephropathy, and electrocardiographic abnormalities. These effects are primarily seen in
acutely poisoned children or in adults from occupational exposures. Lower level exposure
to lead in all humans can affect the synthesis of heme, which, in turn, affects metabolic
processes and decreases vitamin D circulating in the body, reducing calcium stability in the
body.
Inhalation of airborne lead is generally a minor exposure pathway for children, but ingestion
of lead-containing particles in dust can contribute significantly to children's lead exposure
(11). Effects of great concern from low level lead exposure include neurobehavioral
decrement and growth rF tardation in infants exposed prenatally and children exposed
postnatally. . Based on blood lead concentrations, no clear threshold for neurobehavioral
effens has been shown from low level lead exposures resulting in blood lead levels < 10-15
ug/dI (9).
Increased blood pressure from low level lead exposure in middle aged men has been
observed following low level lead exposures. An effects threshold for increased blood
pressure in men has not been defined; several studies have failed to find one while one
longitudinal study suggests of threshold of 30 {tg(dl (16).
T'2 3 r821h!0.006

Animal
In experimental animals, effects associated with exposure to lead and lead compounds are
similar to those in humans. Observed effects have included weight loss, decreased survival,
and neurological, cardiovascular, and Iddney effects. Several studies with experimental
anina,als suggest that lead may interfere with the immune response (5).
Can:inog_enicity
Humen
The EPA has classified lead as a Group B2 Carcinogen. Data concerning the carcinogenicity
of lead in humans are inconclusive. There is no evidence that oral exposure produces a
tumor response. Although studies of occupational inhalation exposure have produced largely
negative results, increases in cancer of the digestive organs, respiratory system and kidney
have been reported (2,6,19)
Aninial
There is evidence in experimental animals that lead salts are carcinogenic in both mice and
rats, resulting in tumors of the lQdneys after either oral or parenteral administration. Most
of the investigations found a carcinogenic response only at the highest -dose. It is unclear
how this effect relates to the lower level exposures typical to humans. Metallic lead, lead
oxode. ;md lead tetralkyls have not been tested adequately. No studies are available on the
carcinogenic potential of lead compounds via inhalation (2).
N
~
Mutagenici ~
~
~
In a number of DNA structure and function assays, lead has been shown to affect the ~
molecular processes associated with the regulation of gene expression. Lead acetate induces ~
T2 4 r821h!0.006

cell transformation in Syrian hamster embryo cells and enhances the incidence of simian
adenowirus induction. Lead oxide demonstrates a similar enhanced adenovirus induction.
Under certain conditions, lead compounds may induce chromosomal aberrations in vivo and
in tis sue cultures. One study showed a relationship between sister chromatid exchange and
lead exposure in exposed workers (2).
Repnyluctive Effects
In exp,crimental animals, various non-teratogenic reproductive effects have been observed
including developmental delays, decreased fertility, and fetotoxicity. No reproductive effects
from human oral exposure to lead have been reported; however, occupational inhalation
exposures have been linked to altered testicular function, increases in spontaneous abortion,
premature delivery, and early membrane rupture (5).
Basis tor Lead Criteria
The classification of lead as B2, probable human carcinogen, is based on sufficient animal
data nd insufficient human data. Ten rat bioassays and one mouse assay showed
statistically significant increases in renal tumors with dietary and subcutaneous exposure to
several soluble lead salts. The most characteristic cancer response is bilateral renal
carcinoma, however; there is some evidence of multiple tumor sites (2).
Cance:r risk due to exposure to lead involves many uncertainties, such as age, health,
nutritiicnal state, body burden and exposure duration which influence the absorption, release
and excretion of lead. In addition, current knowledge of lead pharmacokinetics indicates
that an estimate derived by standard procedures would not truly describe the potential risk.
Therefore, the EPA does not currently recommend a specific cancer potency factor (2).
The water quality criteria of maximum contaminant level goal (MCLG) is based on
neurological effects of lead in infants and adverse effects associated with blood lead levels
T2 5 r821 h! O.00b

of 15 i!tg/dl. Using a conversion factor of 6.25 to convert from blood lead concentrations to
drinldng water lead concentrations and an uncertainty factor of 5, the MCLG of 20 ug/l was
proposed (2).
The Centers for Disease Control (CDC) has defined an elevated blood lead level for
children, which reflects excessive absorption of lead, as a confirmed concentration of lead
in wihole blood of 25 pg/dl or greater (11). This level is based on several studies. For
example, a study of children living near a lead smelter found an erythrocyte protoporphyrin
(EP) response at blood lead levels ranging between 10 and 20 jLg/dl. Although the biologic
threshold for lead toxicity, based on an EP response, is thus less than 20 µgJdl, CDC set the
criteria for screening based on several additional factors including acceptability, cost-
effectiveness, and the feasibility of effective intervention and follow-up. Thus, the CDC-
recommended intervention lead level is 25 pgidl, associated with an EP level of 35 ug/dl or
greater. The CDC is currently reviewing the blood lead level of concern; the guideline is
expected to be revised downward, but it is unclear whether CDC will consider the distinction
between blood lead levels associated with prenatal, and, hence, maternal exposures and
those associated with post-natal exposures. (17).
Risk characterization of lead exposure generally involves using mathematical models to
predict blood lead levels that will result from any given range of lead uptake rates. These
models allow blood lead levels to be related quantitatively to uptake rates and can provide
estimates of the frequency distribution of blood lead levels associated with any given uptake
lead e;irposure scenario.
The Integrated Uptake/Biokinetic (ItJBK) Model, developed for of the U.S. Environmental
Protection Agency, accepts either monitoring data or estimated values for the levels of lead
in various media. The model predicts mean levels of lead in blood, bone, liver, and kidney
for children of different ages. These mean blood lead levels and an estimated geometric
standard deviation for blood lead levels in humans can be combined to predict the frequency
distnlb ution for population blood lead levels (15).
T2 6. r821h!0.006

The Society of Environmental Geochemistry and Health (SEGH)'I'ask Force has developed
a statistical model for estimating acceptable soil lead levels based on a desired mean and
range of blood-lead levels. This model utilizes statistical relationships (developed from
epidemiological analyses) to describe the contn'bution of soil sources and non-soil sources
to blood lead. Unlike the IUBK model, the SEGH model does not require the use of
assumptions for soil-dust transfer coefficients, soil ingestion rates, and lead bioavailability.
Instead, the SEGH model utilizes site-specific environmental health data, such as individual-
specific soil lead and blood lead levels, to determine the slope relationship between soil lead
and blood lead in the population being studied (18). Once the slope relationship has been
established, the frequency distnbution of blood lead levels associated with given soil-lead
levels can be determined.
T2 7 r821hI0e006

References
(1) ACGIH, 1986. Documentation of the Threshold Limit Values and Biological
Exoosure Indices. Fifth Edition. Cincinnati, OH: American Conference of
(2) Governmental Industrial Hygienists. ISBN-0-36712-68-6.
U.S. 'EPA (Office of Health and Environmental Assessment). December 1989.
Integrated Risk Information System (IRIS). Washington, DC EPA/600/8-86-/032b.
(3) U.S. EPA (Office of Emergency and Remedial Response). October 1986. Superfund
Public Health Evaluation Manual. EPA 540/1-86/060.
(4) ACGIH, 1988-87. Threshold Limit Values and Biological Exposure Indices for 1987-
1988. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
ISBN: 0936712-72-4.
(5) Clement Associates, September 27, 1985. Chemical, Physical and Biological
Properties of Compound pound Present at Hazardous Waste Sites. Final Report for U.S.
(6) EPA.
U.S. EPA (Environmental Criteria and Assessment Office). 1984. Health Effects
Assessment for Lead. Cincinnati, OH. Final Report.
(7) U.S. EPA (Environmental Criteria and Assessment Office). 1980. Ambient Water
QualitX Criteria for Lead. Cincinnati, OH. NTIS PB 81-117681.
(8) Doull, J., C.D. Klaassen, M.O. Amdur; 1980. Casarett and Doull's Toxicology: The
Basic Science of Poisons. Second Edition. Macmillan Publishing Co., Inc. ISBN 0-
02-330040-X.
(9) Agency for Toxic Substances and Disease Registry (ATSDR). July 1988. The Natur=
and Extent of Lead Poisoning in Children in the United States: A Report to
Con ess. U.S. Department of Health and Human Services.
(10) Agency for To)ac Substances and Disease Registry (ATSDR). February 19g8.
Toxicological Profile for Lead. U.S. Public Health Service: Atlanta, GA. Draft for
(11) Public Comments.
January
1985
Preventine Lead Poisoning in
Centers for Disease Control (CDC)
.
.
,
Your Children. U.S. Public Health Service, Atlanta, Georgia. N
O
(12)
W
W
and
Sherlock
Smart
Forbes
J
Patterson
J
G
G
I
M
R
Moore
Richards
N N
~
.
.
,
,
.
,
,
.,
.
,
.
.
.
.
,
. ~
T.S. Wi2son. 1982. "Assessment of Lead Intakes and Dose-response for a Population
in Ayr Exposed to a Plumbsolvent Water Supply." Human Toxicol. 1: 115-122.
~
1V
~
T2 8 r821h!0.006

(13) Cools, A., J.A. Salle, M.M. Verberk, and R.L. Zielhuis. 1976. "Biochemical
Response of Male Volunteers Ingesting Inorganic Lead for 49 Days." Int. Arch.
Occup. and Environ. Health. 38: 129-139.
(14) Harley, N.H., and T.H. Kneip. 1985. "An Integrated Metabolic Model for Lead in
Humans of All Ages " Final Report to the U.S. EPA, Contract No. B44899 with New
York University School of Medicine, Dept. of Environmental Medicine, January 30,
1985.
(15) U.S. EPA (Office Of Research & Development). March 1990. Technical Support
Documentaion Lead. Cincinnati, OH. EPA ECAO-CIN-757.
(16) U.S. EPA (Office of Air Quality Planning and Standards). March 1990. Review of
The National Ambient Air quality Standards for Lead: Assessment of Scientific and
Technical Information. Research Triangle Park, NC.
(17) Steele, M.J. August 1990. Personal communication - Gradient Offices. Cambridge
(18) MAe
Gradient Corporation. August 15, 1990. Evaluation of Two Methods to Determine
Cleanup Levels for Lead in Soil. Cambridge MA.
(19) Selevan, S.G., P.J. Landrigan, F.B. Stern and J.H. Jones. 1985. "Mortality of Lead
Smelter Workers." Am. J. Epidemiol. 122: 673-683
dV
O
~
~
~
~
~
~
~
~
T2 9 r821h!0.006
